Form D · Biotechnology
Avstera Therapeutics Corp.
Malvern, PA · CIK 0001878281
Offering snapshot reported Oct 3, 2023 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 19, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 3, 2023 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| May 20, 2022 | Initial | $3,500,000 | No comparison | 3 | SEC filing |
| Aug 12, 2021 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-493670
Source: Form D, filed Oct 3, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karthik Musunuri | Executive |
| Ajay Raju | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
365 Phoenixville Pike
Malvern, PA, 19355
Malvern, PA, 19355